CASE STUDIES
The biotechnology sector has the potential to create wealth, jobs and improve quality of life. Since London is strong in all elements of the biotechnology supply chain, there has been rapid and sustained growth in the number of biotechnology companies in the last decade.
Antisoma
Antisoma’s success is closely tied to its affiliation with London. A cancer therapeutics company, Antisoma acquires rights to new therapeutic candidates though partnerships with internationally recognised academic and cancer research institutions. As such, being positioned in London is vital as it gives access to a wealth of academia and high calibre staff with useful experience and knowledge.
www.antisoma.co.uk
Trigen Ltd
Originally existing as a virtual company, Trigen was able to grow and stabilise due to its London location. London provides Trigen access to seed funds and venture capital. The company is able to develop successful products by means of collaboration with commercial and academic bodies. The access to R & D infrastructure and science and technology among other benefits has proved to be fundamental for Trigen.
www.trigen.co.uk
Arrow Therapeutics
Arrow Therapeutics was founded in 1998 and is already making a significant contribution to anti-infective drug discovery. Arrow has benefited from state of the art laboratories in central London that are designed to standards that rival big pharmaceuticals. Arrow’s facilities house an expert team of over 70 people from London’s highly competitive labour pool.
www.arrowt.co.uk